Ludwig Cancer
@ludwig_cancer
We fund cutting-edge scientific research across multiple Branches and Centers to better understand cancer and eliminate the suffering caused by the disease.
ID: 2259363626
http://www.ludwigcancerresearch.org/ 23-12-2013 20:16:32
3,3K Tweet
5,5K Takipçi
669 Takip Edilen
Study co-led by Ludwig Oncology UNIL CHUV's Douglas Hanahan & Mélanie Tichet shows a new agent, PD1-IL2v, targets killer T cells in tumors, activates them & extends survival of mice with pancreatic cancer. Its effects are enhanced by anti-PD-L1 immunotherapy. bit.ly/3vUPGi4
